Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis
Pharmacology · 2024
DOI: 10.1159/000537968 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pharmacology, 2024. Verfasst von Milorad Stojadinovic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University Clinical Center of Serbia, Belgrade, Serbia. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Drug Interactions. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Introduction
The prevalence of potential drug-drug interactions (pDDIs) is becoming a major safety concern, as it has been previously linked to a significant number of adverse drug events and could have serious consequences for patients, including death. This is especially relevant for patients with chronic renal failure, as they are particularly vulnerable to drug-drug interactions. The aim of this study was to evaluate the prevalence and associated factors of pDDIs in patients receiving chronic peritoneal dialysis.
Methods
An observational, cross-sectional study was conducted on consecutive peritoneal dialysis patients attending four tertiary care hospitals for regular monthly examination. The primary outcome was the number of pDDIs identified using Lexicomp. Potential predictors were determined using multiple linear regression.
Results
Total number of patients included in the study was 140. The results showed that pDDIs were highly prevalent, especially in patients who use antiarrhythmics (p = 0.001), have diabetes mellitus (p = 0.001), recently started peritoneal dialysis (p = 0.003), or have higher number of prescribed drugs (p < 0.001). Number of prescribed drugs (p < 0.001) remained a significant predictor of high-risk pDDIs in addition to the female gender (p = 0.043).
Conclusion
Clinicians should be particularly cautious when prescribing multiple medications to high-risk patients, such as peritoneal dialysis patients, to mitigate the risk of drug-drug interactions and associated adverse health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, University Clinical Center of Serbia, Belgrade, Serbia.
- Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
- Medical Faculty, University of Belgrade, Belgrade, Serbia.
- Department of Nephrology, Clinical Hospital Centre Zemun, Belgrade, Serbia.
- Department of Nephrology, University Clinical Center of Kragujevac, Kragujevac, Serbia.
- Department of Nephrology, Clinical Hospital Centre Zvezdara, Belgrade, Serbia.
Zitieren
APA
Stojadinovic, M., Lausevic, M., Milosevic, I. A., Zaric, R. Z., Jemcov, T. K., Komadina, L., Petrovic, D. S., Djuric, P., Bulatovic, A., Jakovljevic, S., & Jankovic, S. (2024). Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis. Pharmacology. https://doi.org/10.1159/000537968
Vancouver
Stojadinovic M, Lausevic M, Milosevic IA, Zaric RZ, Jemcov TK, Komadina L, et al. Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis. Pharmacology. 2024. doi:10.1159/000537968
BibTeX
@article{Stojadinovic2024,
author = {Stojadinovic, Milorad and Lausevic, Mirjana and Milosevic, Iman Assi and Zaric, Radica Zivkovic and Jemcov, Tamara Kosta and Komadina, Ljiljana and Petrovic, Dejan Slavko and Djuric, Petar and Bulatovic, Ana and Jakovljevic, Stefan and Jankovic, Slobodan},
title = {Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis},
journal = {Pharmacology},
year = {2024},
doi = {10.1159/000537968}
}
EUVIMED